Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function

Molecular Profiling of Multiple Human Cancers Defines an Inflammatory Cancer-Associated Molecular Pattern and Uncovers KPNA2 as a Uniform Poor Prognostic Cancer Marker

(2013) Saleh M. Rachidi et al.   PLoS One

Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?

(2013) L. M. Coussens et al.   SCIENCE

Parkinson's disease in the nuclear age of neuroinflammation

(2013) Yvonne M. Nolan et al.   TRENDS IN MOLECULAR MEDICINE

In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene

(2013) Brandon T. Nokes et al.   Journal of Cancer

Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis

(2013) Noemi Eiró et al.   OncoImmunology

PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices

(2013) Jun Kim et al.   Experimental Neurobiology

Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer

(2012) Hardev Pandha et al.   BJU INTERNATIONAL

Mutational Processes Molding the Genomes of 21 Breast Cancers

(2012) Serena Nik-Zainal et al.   CELL

A truncated tRNA synthetase directs a “translational trickle” of gene expression

(2012) Peng Yao et al.   CELL CYCLE

Cutting Edge: IL-13R 1 Expression in Dopaminergic Neurons Contributes to Their Oxidative Stress-Mediated Loss following Chronic Peripheral Treatment with Lipopolysaccharide

(2012) B. E. Morrison et al.   JOURNAL OF IMMUNOLOGY

Heterotrimeric GAIT Complex Drives Transcript-Selective Translation Inhibition in Murine Macrophages

(2012) A. Arif et al.   MOLECULAR AND CELLULAR BIOLOGY

The breast cancer landscape

(2012) Joe Gray et al.   NATURE

Sequence analysis of mutations and translocations across breast cancer subtypes

(2012) Shantanu Banerji et al.   NATURE

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase

(2012) Tracy L Keller et al.   Nature Chemical Biology

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

(2011) Cheng Fan et al.   BMC Medical Genomics

Developmental transcription factor EN1-a novel biomarker in human salivary gland adenoid cystic carcinoma*

(2011) Diana Bell et al.   CANCER

Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults

(2011) Daniel Alvarez-Fischer et al.   NATURE NEUROSCIENCE

En1 and Wnt signaling in midbrain dopaminergic neuronal development

(2011) Maria TM Alves dos Santos et al.   Neural Development

Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor

(2011) Adriana S. Beltran et al.   PLoS One

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

(2011) V. N. Kristensen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mutually exclusive expression of DLX2 and DLX5/6 is associated with the metastatic potential of the human breast cancer cell line MDA-MB-231

(2010) Monica Morini et al.   BMC CANCER

Targeting HOX and PBX transcription factors in ovarian cancer

(2010) Richard Morgan et al.   BMC CANCER

Clinical implementation of the intrinsic subtypes of breast cancer

(2010) Charles M Perou et al.   LANCET ONCOLOGY

The Transcription Factor Pax6 Regulates Survival of Dopaminergic Olfactory Bulb Neurons via Crystallin αA

(2010) Jovica Ninkovic et al.   NEURON

Molecular Stratification of Triple-Negative Breast Cancers

(2010) C. M. Perou   ONCOLOGIST

HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)

(2009) L Plowright et al.   BRITISH JOURNAL OF CANCER

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

(2009) C. J. Creighton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The GAIT system: a gatekeeper of inflammatory gene expression

(2009) Rupak Mukhopadhyay et al.   TRENDS IN BIOCHEMICAL SCIENCES

Clinicopathological characteristics of triple-negative breast cancers

(2009) Yuka Sasaki et al.   Breast Cancer

Cell-penetrating peptides: from molecular mechanisms to therapeutics

(2008) May C. Morris et al.   BIOLOGY OF THE CELL

Identification of Tumor-Initiating Cells in a p53-Null Mouse Model of Breast Cancer

(2008) M. Zhang et al.   CANCER RESEARCH

Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P

(2008) Liesl Shears et al.   JOURNAL OF UROLOGY

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1

(2008) Mollie H Wright et al.   Molecular Cancer